Amgen, Inc. (AMGN)
443.84
+4.51
(+1.03%)
USD |
NASDAQ |
Aug 24, 16:00
444.00
+0.16
(+0.04%)
After-Hours: 20:00
Amgen Total Assets (Quarterly) : 95.64B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 95.64B |
| March 31, 2026 | 92.50B |
| December 31, 2025 | 90.59B |
| September 30, 2025 | 90.14B |
| June 30, 2025 | 87.90B |
| March 31, 2025 | 89.37B |
| December 31, 2024 | 91.84B |
| September 30, 2024 | 90.88B |
| June 30, 2024 | 90.91B |
| March 31, 2024 | 92.98B |
| December 31, 2023 | 97.15B |
| September 30, 2023 | 90.53B |
| June 30, 2023 | 90.27B |
| March 31, 2023 | 88.72B |
| December 31, 2022 | 65.12B |
| September 30, 2022 | 63.70B |
| June 30, 2022 | 59.29B |
| March 31, 2022 | 59.20B |
| December 31, 2021 | 61.16B |
| September 30, 2021 | 64.99B |
| June 30, 2021 | 59.77B |
| March 31, 2021 | 62.54B |
| December 31, 2020 | 62.95B |
| September 30, 2020 | 64.64B |
| June 30, 2020 | 65.01B |
| Date | Value |
|---|---|
| March 31, 2020 | 61.67B |
| December 31, 2019 | 59.71B |
| September 30, 2019 | 59.54B |
| June 30, 2019 | 59.37B |
| March 31, 2019 | 64.00B |
| December 31, 2018 | 66.42B |
| September 30, 2018 | 67.33B |
| June 30, 2018 | 67.68B |
| March 31, 2018 | 71.16B |
| December 31, 2017 | 79.95B |
| September 30, 2017 | 80.33B |
| June 30, 2017 | 79.59B |
| March 31, 2017 | 77.86B |
| December 31, 2016 | 77.63B |
| September 30, 2016 | 78.15B |
| June 30, 2016 | 75.47B |
| March 31, 2016 | 75.12B |
| December 31, 2015 | 71.58B |
| September 30, 2015 | 71.87B |
| June 30, 2015 | 71.21B |
| March 31, 2015 | 68.95B |
| December 31, 2014 | 69.01B |
| September 30, 2014 | 70.78B |
| June 30, 2014 | 69.53B |
| March 31, 2014 | 67.00B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 49.36B |
| Regeneron Pharmaceuticals, Inc. | 41.73B |
| AbbVie, Inc. | 135.12B |
| Biogen, Inc. | 32.09B |
| Vertex Pharmaceuticals, Inc. | 27.42B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 83.95B |
| Shareholders Equity (Quarterly) | 11.69B |
| Debt to Equity Ratio | 4.903 |
| Current Ratio | 1.371 |
| Net Debt Paydown Yield | 0.01% |